Tian Wang

Dr. Tian Wang is a Postdoctoral Research Fellow at The George Institute for Global Health, focusing on cardiovascular disease, hypertension management, nutrition, and implementation science. She employs multidisciplinary approaches to enhance cardiometabolic outcomes through pharmaceutical strategies like single-pill combination therapy and non-pharmaceutical interventions such as dietary adjustments.

Her notable work includes leading the national evaluation of Australia’s 60-day dispensing policy for antihypertensive medicines and analyzing the GMRx2 international trials to assess blood pressure variability as a cardiovascular risk marker. Dr. Wang has secured over $190,000 in research funding, published in prestigious journals like the European Heart Journal and JAMA Network Open, and presented at 14 national and international conferences.

• Affiliation: The George Institute for Global Health, UNSW, University of Sydney
• Roles: Research Fellow, Accredited Practising Dietitian, educator in curriculum development and supervision

Scientific Awards

• Prize finalist at the 2025 Cardiac Society of Australia and New Zealand Conference

Dr. Wang is actively involved in national committees, including Hypertension Australia’s EMCR Committee and the Nutrition Society of Australia working group, advocating for equity and leadership development among early-career researchers.